Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
Sales | 20,341 | 24,657 | 18,544 | 15,835 | 10,852 |
Cost of Goods | 6,092 | 1,684 | 2,063 | 705 | 381 |
Gross Profit | 14,249 | 22,973 | 16,481 | 15,130 | 10,471 |
Operating Expenses | 58,281 | 73,595 | 59,871 | 61,910 | 59,004 |
Operating Income | -43,940 | -49,938 | -43,327 | -46,075 | -48,152 |
Other Income | -5,222 | -5,126 | -6,075 | -1,089 | 111 |
Pre-tax Income | -49,162 | -55,064 | -49,402 | -47,164 | -48,041 |
Income Tax | -33 | N/A | N/A | N/A | -90 |
Net Income Continuous | -49,129 | -55,064 | -49,402 | -47,164 | -47,951 |
Net Income | $-49,129 | $-55,064 | $-49,402 | $-47,164 | $-47,951 |
EPS Basic Total Ops | -1.07 | -1.20 | -1.09 | -1.04 | -1.06 |
EPS Basic Continuous Ops | -1.07 | -1.21 | -1.09 | -1.04 | -1.06 |
EPS Diluted Total Ops | -1.07 | -1.20 | -1.09 | -1.04 | -1.06 |
EPS Diluted Continuous Ops | -1.07 | -1.21 | -1.09 | -1.04 | -1.06 |
EBITDA(a) | $-35,764 | $-41,769 | $-40,492 | $-41,634 | $-45,483 |